Literature DB >> 16400147

Alterations in 5-HT1B receptor function by p11 in depression-like states.

Per Svenningsson1, Karima Chergui, Ilan Rachleff, Marc Flajolet, Xiaoqun Zhang, Malika El Yacoubi, Jean-Marie Vaugeois, George G Nomikos, Paul Greengard.   

Abstract

The pathophysiology of depression remains enigmatic, although abnormalities in serotonin signaling have been implicated. We have found that the serotonin 1B receptor [5-hydroxytryptamine (5-HT1B) receptor] interacts with p11. p11 increases localization of 5-HT1B receptors at the cell surface. p11 is increased in rodent brains by antidepressants or electroconvulsive therapy, but decreased in an animal model of depression and in brain tissue from depressed patients. Overexpression of p11 increases 5-HT1B receptor function in cells and recapitulates certain behaviors seen after antidepressant treatment in mice. p11 knockout mice exhibit a depression-like phenotype and have reduced responsiveness to 5-HT1B receptor agonists and reduced behavioral reactions to an antidepressant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400147     DOI: 10.1126/science.1117571

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  187 in total

1.  Serotonin 1B receptor imaging in pathological gambling.

Authors:  Marc N Potenza; Espen Walderhaug; Shannan Henry; Jean-Dominique Gallezot; Beata Planeta-Wilson; Jim Ropchan; Alexander Neumeister
Journal:  World J Biol Psychiatry       Date:  2011-09-22       Impact factor: 4.132

2.  Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans.

Authors:  Jennifer L Warner-Schmidt; Kimberly E Vanover; Emily Y Chen; John J Marshall; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 3.  Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy.

Authors:  Richard L Hauger; J Alberto Olivares-Reyes; Frank M Dautzenberg; James B Lohr; Sandra Braun; Robert H Oakley
Journal:  Neuropharmacology       Date:  2011-11-25       Impact factor: 5.250

Review 4.  Linking molecules to mood: new insight into the biology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

5.  Kinetics of G-protein-coupled receptor endosomal trafficking pathways revealed by single quantum dots.

Authors:  Katye M Fichter; Marc Flajolet; Paul Greengard; Tania Q Vu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-12       Impact factor: 11.205

6.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

7.  Alteration by p11 of mGluR5 localization regulates depression-like behaviors.

Authors:  K-W Lee; L Westin; J Kim; J C Chang; Y-S Oh; B Amreen; J Gresack; M Flajolet; D Kim; A Aperia; Y Kim; P Greengard
Journal:  Mol Psychiatry       Date:  2015-09-15       Impact factor: 15.992

8.  p11 modulates L-DOPA therapeutic effects and dyskinesia via distinct cell types in experimental Parkinsonism.

Authors:  Nicoletta Schintu; Xiaoqun Zhang; Alexandra Alvarsson; Roberta Marongiu; Michael G Kaplitt; Paul Greengard; Per Svenningsson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

9.  Antidepressant effects on serotonin 1A/1B receptors in the rat brain using a gene x environment model.

Authors:  Stal Saurav Shrestha; Daniel S Pine; David A Luckenbaugh; Katarina Varnäs; Ioline D Henter; Robert B Innis; Aleksander A Mathé; Per Svenningsson
Journal:  Neurosci Lett       Date:  2013-11-25       Impact factor: 3.046

Review 10.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.